Capstan Medical
Focus: Capstan Medical is a cardiovascular-focused medical device company specializing in transcatheter mitral valve replacement systems based in Santa Cruz, CA. The company is in early clinical development with a single ongoing trial for its lead Capstan System.
Profile data last refreshed 20h ago · AI intelligence enriched 3w ago
Open Jobs
23+3 this month
Stable — net +3 jobs in 30d
6 added, 3 removed. Backfill posture.
Should You Work at Capstan Medical?
AI assessmentCapstan offers early-stage device upside and specialized focus but carries pre-clinical risk; best for professionals comfortable with 5+ year development timelines and venture-backed volatility.
Why Work Here
- Early-stage device company with focused pipeline in high-unmet-need mitral regurgitation market—opportunity to shape product development trajectory from clinical proof-of-concept
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Capstan System transcatheter mitral valve replacement
Mitral RegurgitationClinical Trials (1)
NCT06600191Capstan Medical TMVR Study: FIH
N/AHelp build intelligence for Capstan Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.